445results about How to "Reduce depression" patented technology

A magnetic recording medium includes, in the following order: a backcoat layer; a nonmagnetic support; a nonmagnetic layer containing a nonmagnetic powder and a binder; and a magnetic layer containing a ferromagnetic powder and a binder, wherein the backcoat layer contains particles having an average primary particle size D50 of from 0.05 to 1.0 μm and forming substantially no aggregates nor agglomerates in the backcoat layer.

Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).

The present invention relates to compositions and methods for treating depression. The compositions and methods comprise the use of anti-inflammatory compounds alone or in combination with antidepressant compounds to down regulate HPA activation through the targeting of peripheral (non-CNS) cytokines.

First laser light is irradiated (energy density of 400 to 500 mj/cm2) to a semiconductor film 102 in an atmosphere containing oxygen in order to obtain a semiconductor film 102b having large depressions and projections on the surface. Then, an oxidized film 105a formed by the irradiation of the first laser light is removed. After that, an inert gas with an oxygen density of 10 ppm or below is blown thereto, and, at the same time, second laser light is irradiated thereto (the energy density is higher than that of the irradiation of the first laser light). Thus, the surface of the semiconductor film 102b is flattened, and a semiconductor film 102c having fewer depressions and projections on the surface can be obtained.

The invention relates to a noninvasive radiotherapy system for a robot, and belongs to the medical equipment field. The noninvasive radiotherapy system for the robot consists of seven modules, i.e. a radiotherapy planning system, a three-dimensional numerical-control therapy bed, an automatic tracking system for a four-dimensional real-time image, a robot system, a radioactive source, an adjuvant therapy system and an integrated control system, wherein the automatic tracking system for the four-dimensional real-time image consists of a six-freedom-of-degree G-shaped arm real-time image system and an intelligent tracking system; the six-freedom-of-degree G-shaped arm real-time image system is formed by successively connecting a G-shaped arm, a G-shaped arm sliding rail, a G-shaped arm spindle, a G-shaped arm pitch shaft and a G-shaped arm sliding seat; an X ray source and an X ray dynamic flat panel detector are formed into one group, and two groups are correspondingly installed on the G-shaped arm; and the G-shaped arm sliding seat is installed in a rail (9). According to the noninvasive radiotherapy system for the robot, which is disclosed by the invention, the defects of unmatched projection time, time waste and low therapy precision in the prior art are overcome, the precise therapy of the whole body tumor can be carried out, and the cardiovascular disease therapy and the noninvasive regulation of the renal nerve disease can be carried out.

The invention provides pharmaceutical compositions comprising short single stranded oligonucleotides, of length of between 8 and 26 nucleobases which are complementary to human microRNAs selected from the group consisting of miR19b, miR21, miR122a, miR155 and miR375. The short oligonucleotides are particularly effective at alleviating miRNA repression in vivo. It is found that the incorporation of high affinity nucleotide analogues into the oligonucleotides results in highly effective anti-microRNA molecules which appear to function via the formation of almost irreversible duplexes with the miRNA target, rather than RNA cleavage based mechanisms, such as mechanisms associated with RNaseH or RISC.

Systems, devices and methods for applying therapeutic transcranial magnetic stimulation (TMS) to at least one superficial cortical target brain region and at least one deep brain target so that the induced current points between the superficial cortical and deep brain targets. Systems may include two TMS electromagnets configured for treating a patient by stimulating at least one deep brain region with one TMS magnet at the same time that a second TMS magnet stimulates at least one superficial cortical brain region. Also described are positioners to secure at least two TMS magnets in a substantially fixed arrangement relative to the patient's head, while allowing for fine adjustment of position and orientation of each of the TMS magnets individually to conform them to the shape of the contact surface of the body and to direct the vector direction of the overall induced current from the magnets.

A method for motivating a user including the steps of providing a device with an image capturing feature; capturing an image of the user with the image capturing feature; transmitting the captured image to an identity verification device; comparing biometric data from the image to a biometric profile provided by the user; generating a motivational image of the user with a processing device, the motivational image being produced from an acquired image of the user, the acquired image depicting at least one feature of the user; and displaying the motivational image from the processing device in substantially real time to the user; wherein the motivational image exclusively depicts a real image of the user having enhanced dimensions for the at least one feature.

The invention provides a completely oral medicament for treating acquired immune deficiency syndrome (AIDS), comprising the following components: hedyotis diffusa, honeysuckle, meadowrueleaf corydalis root, dandelion, weeping forsythia, asparagus, ophiopogon root, figwort root, fresh rehmannia root, peach kernel, chuanxiong rhizome, zedoary, achyranthes root, dahurian patrinia herb, giant knotweed, stiff silkworm, isatis root, white peony root, polygonatum, bitter caramon, mistletoe, tortoise plastron, glossy privet fruit, oyster, pollen, salvia miltiorrhiza, tree peony bark, bupleurum, bitter orange, cimicifuga foetida, dried orange peel, amomum fruit, officinal magnolia bark, rose, songaria cynomorium herb, self-heal, medicine terminalia fruit, gromwell, licorice, chrysanthemum, castor bean, bullfrog gallbladder, baikal skullcap root, medicated leaven, malt, rice sprout, chicken's gizzard-skin, radish seed, scorch-fried crataegus, Chinese yam, astragalus root, bighead atractylodes rhizome, sealwort, dangshen, prepared rehmannia root, cornus fruit, tuckahoe, jujube, Chinese wolfberry, cistanche, dragon bone, oyster, epimedium, curculigo root, deerhorn glue, ginseng, donkey-hide glue, white fungus, angelica, spatholobus stem and turtle shell. The medicament provided by the invention not only can cure AIDS and has good therapeutic effect on AIDS, but also can prevent infection of AIDS.

The present invention concerns a new method for the biological preparation of a diol comprising culturing a microorganism genetically modified for the bioproduction of an aliphatic diol, wherein the microorganism comprises a metabolic pathway for the decarboxylation of a hydroxy-2-keto-aliphatic acid metabolite with an enzyme having a 2-keto acid decarboxylase activity, the product obtained from said decarboxylation step being further reduced into the corresponding aliphatic diol, and wherein the microorganism is genetically modified for the improved production of said hydroxy-2-keto-aliphatic acid metabolite.

The invention also concerns a modified microorganism for the production of an aliphatic diol.

An infusor system for administering medications to a venous blood vessel in the body of a patient. The infusor system includes a flexible, elongated delivery tube having opposite ends. One of the ends is couplable to a supply of liquid medication, which is remote from the venous blood vessel. The system further includes a delivery component coupled to the other end of the delivery tube. This delivery component is adaptable to be placed in confronting relationship with the venous blood vessel so that medication from said supply may be introduced directly into the venous blood vessel and distributed in the body of the patient. The infusor system further includes a pressure-altering device used for increasing intraabdominal pressure in the body of the patient. Sampling of venous blood from the meningorrhachidian vasculature is also possible.

The invention relates to a smart cruise control system and a control method therefor. A selecting mode or a learning mode of learning driving habits of a driver is achieved according to changes of target accelerated speed with time of a vehicle. The smart cruise control system comprises a distance error calculating portion used for calculating a distance error by utilizing distance and target distance between a self vehicle and a front vehicle measured by a sensor, a relative speed calculating portion used for calculating relative speed by speed of the self vehicle and the front vehicle measured by a speed measuring portion, a driving mode selecting portion via which the driver can select driving modes, and a target accelerated speed calculating portion used for calculating target accelerated speed by utilizing first accelerated speed calculated by the distance error and a first medium variate and utilizing second accelerated speed calculated by speed of the self vehicle and a second medium variate and utilizing third accelerated speed calculated by relative speed and a third medium variate according to the selected driving modes.

The invention discloses a VR technology-based depression auxiliary treatment virtual scene system and a realization method for the same. The system comprises a virtual scene interaction module, a data collection module and a data analysis module all connected with each other, wherein the virtual scene interaction module has a VR device; the virtual scene interaction module is connected with the data collection module via the VR device; the data analysis module has a database; the virtual scene interaction module further comprises an environment module, a role module and plot module; the environment module has a place module, a sound module, a color module and a weather module; the data collection module has a physiological data module and a subjective feeling module; and the data analysis module has the database and a data processing module. Under correct instructions and rational use of an immersion type experience treatment method based on the virtual scene system, a depression mood can be alleviated.

A semiconductor device of the present invention has a first conductive layer, a second conductive layer, an insulating layer which is formed between the first conductive layer and the second conductive layer and which has a contact hole, and a third conductive layer which is connected to the first conductive layer and the second conductive layer and of which at least a part of an end portion is formed inside the contact hole. Near a contact hole where the second conductive layer is connected to the third conductive layer, the third conductive layer does not overlap with the second conductive layer with the first insulating layer interposed therebetween and an end portion of the third conductive layer is not formed over the first insulating layer. This allows suppression of depression and projection of the third conductive layer.

The invention relates to a method for producing an interior wall healthcare latex paint by using lavender natural extract, which comprises the following steps: A) mixing surface-active agent, lavender essential oil and sustained-release agent, and stirring the mixture at a low speed at 20-30 DEG C for 20 minutes; B) keeping stirring at the low speed, adding the mixture obtained in step A) evenly into latex, and stirring for 10 minutes; C) adding water, titanium pigment, filling material and partial additives in accordance with formula quantity into a new agitation tank, and stirring at a high speed for 20 minutes; D) sending the materials obtained in step C) into a sand mill to grind until the fineness of the granule is less than 30mu m, and lowering the materials temperature below 30 DEG C; E) keeping stirring at the low speed, adding the mixture obtained in step B) slowly into the materials obtained in step D); and F) keeping stirring at the low speed, adding the surplus additives, and adjusting to get the expected viscosity, thus obtaining the product. The product has healthcare efficacy.

The present invention relates to a process to produce a composition comprising water-soluble peptides and having a Trp/LNAA ratio of more than 0.15, which comprises hydrolyzing lysozyme, preferably hen eggs lysozyme, to prepare a hydrolysate having a DH of between 5 and 45.

The invention relates to a maca function beverage which comprises the following raw materials in percentage by weight: 96.5%-98.7% of purified water, 0.5%-2.0% of maca extract liquid, 0.5%-0.8% of sorbitol liquid and 0.04%-0.06% of sorbic acid. The maca function beverage is a pure natural beverage, has the effects of remarkably improving human body immunity, resisting fatigue, replenishing energy and improving human body energy, has a body building effect after being drunk for a long term, and does not have side effects. A preparation method of the maca function beverage is provided.

The invention discloses a hand five-finger rehabilitation training and correction device and relates to the technical field of rehabilitation devices. An upper box body and a lower box body are connected in a matched mode, a containing cavity is formed in the inside, a hand training mechanism is fixed to the upper box body, prime mover mechanisms are arranged in the containing cavity and transfer power to the hand training mechanism through a transmission mechanism, the hands are driven to perform rehabilitation training. The hand five-finger rehabilitation training and correction device is provided with two different prime mover mechanisms, adopts hand-cranking and motor hybrid drive and provides active, passive and cooperated training modes, the designed hand-cranking drive is used for healthy limb training and promoting rehabilitation of a hand nerve function and a double-side cooperated function, a more simplified parallel six-rod mechanism is adopted, and the actual holding rule of the hands is greatly recovered. Quick and convenient dismounting of a drive rod and adjustment of a drive rod installing position are achieved through exercise and limiting of a secondary slide block, thus the exercise angles of knuckles are adjusted in a certain range, and the hand five-finger rehabilitation training and correction device achieves the purposes of meeting different rehabilitation training demands and achieving personalized training.

A method for improving the bioavailability of a bioactive substance includes subjecting the bioactive substance to laser radiation. The laser radiation modifies the bioactive substance to thereby modify reactions relating thereto in the body. The method enables reductions in inflammation associated with autoimmune diseases, modification of reaction by-products in the body, increased homogenization and flattening of molecular shape and improved methylation. The improved methylation can be utilized to reduce homocysteine blood levels, and to reduce anxiety, depression, paranoia, hostility, somatization (perception of bodily distress) and obsessive-compulsive symptoms. Enhanced nitric oxide generation from modified L-arginine can be used to reduce systolic and diastolic blood pressure, lower total and LDL cholesterol levels, and improve the ratio of total to HDL cholesterol. Increased depth of penetration of sparse constructive nodes of laser radiation may increase the range of photodynamic therapy applications and a wide range of in vitro and in vivo modifications of molecular shape and activity. Laser acoustic resonance can be utilized to increase the homogeneity of crystals, or favor the generation of novel or preferred crystalline forms.

Disclosed is an optical fiber article for receiving pump radiation of a first wavelength for amplifying or generating radiation of a second wavelength. The optical fiber article includes a core for propagating light of the second wavelength. The core has a first index of refraction and includes a rare earth material. A cladding surrounds the core and has a second index of refraction that is less than the first index of refraction. The outer circumference of the cladding can include a plurality of sections, where the plurality of sections includes at least one substantially straight section and one inwardly curved section. The optical fiber article can also include at least one outer layer surrounding the cladding, where the index of refraction of the outer layer is less than the second refractive index. Methods for producing the optical fiber article are also disclosed, as well as methods for providing a preform for drawing such an optical fiber article.

The present invention provides a compound of the formula: Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly reduced bones mass, osteoporosis, osteopenia, or reduced muscle mass or strength, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof. X-17142.

A method of producing a sugar free chocolate composition comprising the steps of: thoroughly mixing at least the following ingredients: 1 to 60% by weight agave syrup; and 25 to 99% by weight cacao liquor; so as to produce an aqueous solution; conching the aqueous solution; evaporating water from the aqueous solution utilizing an additional water removal means during the conching step to provide a conched chocolate; tempering the conched chocolate to provide a chocolate product; and forming the chocolate product.

The invention discloses a composition of ginsenoside Rg3 and ginsenoside Rg5, a preparation method of the composition, and application of the composition to medicines, foods and health-care products for improving immunity, resisting tumors, resisting medicine resistance of tumor targeted medicines, relieving chemoradiotherapy toxic and side effects, resisting fatigue and resisting depression. Thecomposition can quickly take effect, has small toxic and side effects, can be taken for a long time, belongs to a safe, efficient and stable medicine and health care food with a simple preparation process, is suitable for industrial production, and can be easily popularized. The invention provides a novel raw material and production process for medicines and foods for improving immunity, resistingtumors, resisting medicine resistance of tumor targeted medicines, relieving chemoradiotherapy toxic and side effects, resisting fatigue and resisting depression.